Renna L V, Cardani R, Botta A, Rossi G, Fossati B, Costa E, Meola G
University of Milan.
Eur J Histochem. 2014 Oct 22;58(4):2444. doi: 10.4081/ejh.2014.2444.
Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are multisystemic disorders linked to two different genetic loci and characterized by several features including myotonia, muscle weakness and atrophy, cardiac dysfunctions, cataracts and insulin-resistance. In both forms, expanded nucleotide sequences cause the accumulation of mutant transcripts in the nucleus deregulating the activity of some RNAbinding proteins and providing an explanation for the multisystemic phenotype of DM patients. However this pathogenetic mechanism does not explain some histopathological features of DM skeletal muscle like muscle atrophy. It has been observed that DM muscle shares similarities with the ageing muscle, where the progressive muscle weakness and atrophy is accompanied by a lower regenerative capacity possibly due to the failure in satellite cells activation. The aim of our study is to investigate if DM2 satellite cell derived myoblasts exhibit a premature senescence as reported for DM1 and if alterations in their proliferation potential and differentiation capabilities might contribute to some of the histopathological features observed in DM2 muscles. Our results indicate that DM myoblasts have lower proliferative capability than control myoblasts and reach in vitro senescence earlier than controls. Differentely from DM1, the p16 pathway is not responsible for the premature growth arrest observed in DM2 myoblasts which stop dividing with telomeres shorter than controls. During in vitro senescence, a progressive decrease in fusion index is observable in both DM and control myotubes with no significant differences between groups. Moreover, myotubes obtained from senescent myoblasts appear to be smaller than those from young myoblasts. Taken together, our data indicate a possible role of DM2 premature myoblast senescence in skeletal muscle histopathological alterations i.e., dystrophic changes and type 2 fibre atrophy.
1型强直性肌营养不良(DM1)和2型强直性肌营养不良(DM2)是与两个不同基因位点相关的多系统疾病,其特征包括肌强直、肌肉无力和萎缩、心脏功能障碍、白内障和胰岛素抵抗。在这两种类型中,核苷酸序列的扩增导致突变转录本在细胞核中积累,从而使一些RNA结合蛋白的活性失调,这为DM患者的多系统表型提供了解释。然而,这种致病机制并不能解释DM骨骼肌的一些组织病理学特征,如肌肉萎缩。据观察,DM肌肉与衰老肌肉有相似之处,在衰老肌肉中,进行性肌肉无力和萎缩伴随着再生能力的降低,这可能是由于卫星细胞激活失败所致。我们研究的目的是调查DM2卫星细胞来源的成肌细胞是否如DM1那样表现出早衰,以及它们增殖潜力和分化能力的改变是否可能导致DM2肌肉中观察到的一些组织病理学特征。我们的结果表明,DM成肌细胞的增殖能力低于对照成肌细胞,并且比对照更早达到体外衰老。与DM1不同,p16通路与DM2成肌细胞过早生长停滞无关,DM2成肌细胞停止分裂时端粒比对照短。在体外衰老过程中,DM和对照肌管的融合指数均逐渐下降,两组之间无显著差异。此外,从衰老成肌细胞获得的肌管似乎比从年轻成肌细胞获得的肌管更小。综上所述,我们的数据表明DM2成肌细胞过早衰老可能在骨骼肌组织病理学改变即营养不良性变化和2型纤维萎缩中起作用。